Zobrazeno 1 - 10
of 299
pro vyhledávání: '"John L, Neumeyer"'
Publikováno v:
Chemistry, Vol 3, Iss 3, Pp 1047-1056 (2021)
The dopamine D2 agonist MCL-524 is selective for the D2 receptor in the high-affinity state (D2high), and, therefore, the PET analogue, [18F]MCL-524, may facilitate the elucidation of the role of D2high in disorders such as schizophrenia. However, th
Externí odkaz:
https://doaj.org/article/5a1916e91d404f2aa0245d4f9b0a550a
Autor:
Youbai Chen, Alan B. Packard, John L. Neumeyer, Anna W. Sromek, Vamsidhar Akurathi, James A. H. Inkster
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Fluorine-18 radiolabeling typically includes several conserved steps including elution of the [18F]fluoride from an anion exchange cartridge with a basic solution of K2CO3 or KHCO3 and Kryptofix 2.2.2. in mixture of acetonitrile and water followed by
Publikováno v:
Chemistry
Volume 3
Issue 3
Pages 75-1056
Chemistry, Vol 3, Iss 75, Pp 1047-1056 (2021)
Volume 3
Issue 3
Pages 75-1056
Chemistry, Vol 3, Iss 75, Pp 1047-1056 (2021)
The dopamine D2 agonist MCL-524 is selective for the D2 receptor in the high-affinity state (D2high), and, therefore, the PET analogue, [18F]MCL-524, may facilitate the elucidation of the role of D2high in disorders such as schizophrenia. However, th
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:230-233
A series of novel aporphine derivatives were synthesized for initial screening at the 5-HT2 receptor subtypes. Among them, Compounds 11a and 11b were identified as potent 5-HT2C hit ligands with high selectivity over other 5-HT2 receptor subtypes. Mo
Publikováno v:
ACS Chem Neurosci
The dopamine D(2) receptor exists in two different states, D(2)(high) and D(2low); the former is the functional form of the D(2) receptor and associates with intracellular G-proteins. The D(2) agonist [(3)H]MCL-536 has high affinity for the D(2) rece
Publikováno v:
ACS Chem Neurosci
Increases in the D2 receptor high affinity state are associated with certain neurological disorders. We synthesized and characterized the high-affinity D2high ligand [(3)H]MCL-536 in competition binding against the D2/3 agonist R-(−)-N-n-propylnora
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5811 (2009)
(+/-) SKF83959, like many other arylbenzazepines, elicits powerful neuroprotection in vitro and in vivo. The neuroprotective action of the compound was found to partially depend on its D(1)-like dopamine receptor agonistic activity. The precise mecha
Externí odkaz:
https://doaj.org/article/7508d982aa0449b3b4b8a817edb57a18
Autor:
Peter Jenner, Anna W. Sromek, Andrew J. Lees, Louise Lincoln, Sarah Rose, Michael J. Jackson, John L. Neumeyer, Ria Fisher
Publikováno v:
Movement Disorders. 31:1381-1388
Background The D1/D2 dopamine agonist apomorphine has poor oral bioavailability, necessitating subcutaneous administration in the treatment of Parkinson's disease (PD). Acute subcutaneous injection is used as rescue therapy from “off” periods, wh
Publikováno v:
Bioorganicmedicinal chemistry letters. 29(2)
A series of novel aporphine derivatives were synthesized for initial screening at the 5-HT
Convenient synthesis of18F-radiolabeled R-(−)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphine
Autor:
David Alagille, Gilles Tamagnan, Shaohui Zhang, John L. Neumeyer, R. M. Baldwin, Thomas J. Morley, Vamsidhar Akurathi, Wei Li, Anna W. Sromek, Alan B. Packard
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 57:725-729
Aporphines are attractive candidates for imaging D2 receptor function because, as agonists rather than antagonists, they are selective for the receptor in the high affinity state. In contrast, D2 antagonists do not distinguish between the high and lo